英文药名：GLUCONSAN K Tablets（Potassium gluconate） 中文药名：葡萄糖酸钾片 生产厂家：科研制药 グルコンサンＫ錠５ｍＥｑ／グルコンサンＫ錠２．５ｍＥｑ 治疗类别名称 补钾 一般名： Potassium gluconate (グルコン酸カリウム) 分子式： C6H11KO7 分子量： 234.25 構造式： 性状： 本产品是淡黄色结晶粉末或颗粒，不闻白，味道微苦。 它是易溶于水，易溶于冰醋酸，并在无水乙醇，乙醚，氯仿几乎不溶。 此产品（1→25）的水溶液的pH为6.9至7.8。 熔点： 约178℃（分解） 适应症 钾在低钾状态供应 用法用量 钾10mEq大量一次的三到四倍口服给药。 它是根据症状调整。 药效药理 钾离子在细胞内基本阳离子维持在细胞中的紧张，神经冲动的传导，心脏收缩，骨骼肌和平滑肌的收缩和保持操作正常肾功能最身体组织它被示出。在钾盐葡糖酸钾电解质平衡示出小的药理作用是阴离子部分 - 显示调节等（与基座平衡相关的酸）的效果。 包装规格 钙片剂 5mEq：100片，1000片（PTP包装），1000片（瓶包装） 2.5mEq：100片，1000片（PTP包装），1000片（瓶包装） 制造厂商 科研制药有限公司 GLUCONSAN K Tablets（Potassium gluconate） GLUCONSAN K Tablets 2.5mEq（グルコンサンK錠2.5mEq）  Brand name : GLUCONSAN K Tablets 2.5mEq 　Active ingredient: Potassium gluconate 　Dosage form: white tablet, major axis: 16.2mm, minor axis: 7.1mm, thickness: 4.7mm 　Print on wrapping: (Face) KY03, グルコンサンＫ錠2.5mEq, GLUCONSAN K2.5mEq, 2.5mEq (Back) グルコンサンＫ錠2.5mEq, カリウム2.5mEq相当量 GLUCONSAN K Tablets 5mEq（グルコンサンK錠5mEq）  Brand name : GLUCONSAN K Tablets 5mEq 　Active ingredient: Potassium gluconate 　Dosage form: white tablet, major axis: 19.2mm, minor axis: 7.9mm, thickness: 7.8mm 　Print on wrapping: （Face）KY 02 グルコンサンK錠5mEq GLUCONSAN K5mEq 5mEq （Back）グルコンサンK錠5mEq カリウム5mEq相当量 Effects of this medicine This medicine shows conservation of cell equilibrium, conduction of nerve impulse, contraction of heart or muscle, retaining effect of normal renal function or acid-base balance control as potassium ion. It is usually used to supply potassium in patients with hypokalemic conditions. Before using this medicine, be sure to tell your doctor and pharmacist •If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines. If you have: renal dysfunction, Addison's disease that have not been treated properly, hyperkalemia or gastrointestinal transit disorder. •If you are pregnant or breastfeeding. •If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.) Dosing schedule (How to take this medicine) •Your dosing schedule prescribed by your doctor is <<to be written by a healthcare professional>> •In general, for adults, take 4 tablets (10 mEq equivalent of the potassium) at a time, 3 to 4 times a day. The dosage may be adjusted according to your age or symptoms. Strictly follow the instructions. •If you miss a dose, take a dose as soon as possible when you noticed. If it is almost time for the next dose, skip the missed dose and follow your regular dosing schedule. You should never take two doses at one time. •If you accidentally take more than your prescribed dose, consult with your doctor or pharmacist. •Do not stop taking this medicine unless your doctor instructs you to do so. Precautions while taking this medicine • Possible adverse reactions to this medicine The most commonly reported adverse reactions include loss of appetite and nausea/vomiting. If any of these symptoms occur, consult with your doctor or pharmacist. The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately. •faint, dizziness [cardiac conduction defect] The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above. Storage conditions and other information •Keep out of the reach of children. Store away from direct sunlight, heat and moisture. •Discard the remainder. Do not store them. Kaken Pharmacetical Co.,LtdInternal Published: 4/2008 The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment. http://www.info.pmda.go.jp/go/pack/3229007C1032_2_04/